| Financial Year |
March 31 2023 |
| Monetary Funds |
2,180,753,311.57 |
| Held-for-trading Financial Assets |
11,727,499.23 |
| Notes Receivable |
7,665,793.99 |
| Accounts Receivable |
867,310,013.75 |
| Advances to Suppliers |
93,387,685.49 |
| Other Receivables |
94,892,181.22 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,468,516,830.13 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
44,048,344.06 |
| Total Current Assets |
4,783,406,131.67 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
4,810,014,499.53 |
| Under-construction Projects |
783,951,153.39 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
191,426,401.57 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
38,724,540.01 |
| Other Non-Current Assets |
474,908,941.10 |
| Sub-Total of Non-Current Assets |
6,343,226,999.30 |
| Total Assets |
11,126,633,130.97 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
26,283,438.05 |
| Notes Payable |
216,135,722.07 |
| Accounts Payable |
753,436,007.87 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
63,154,408.14 |
| Taxes Payable |
47,358,912.98 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
120,112,154.30 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
16,081,416.38 |
| Other Current Liabilities |
5,325,206.69 |
| Sub-Total of Current Liabilities |
1,277,501,385.60 |
| Long-term Loans |
-- |
| Bonds Payable |
1,905,931,730.52 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
8,619,683.22 |
| Deferred Income Tax Liabilities |
54,373,970.81 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
2,059,797,675.99 |
| Total Liabilities |
3,337,299,061.59 |
| Paid-In Capital(Or Share Stock) |
649,671,593.00 |
| Capital Surplus |
2,348,622,818.37 |
| Surplus Reserve |
106,111,011.18 |
| LESS:Treasury Stock |
67,505,653.00 |
| Undistributed Profits |
4,209,995,043.58 |
| Minority Stockholder's Interest |
155.26 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
7,789,333,914.12 |
| Owner's Equity（Stockholder's Equity） |
7,789,334,069.38 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
11,126,633,130.97 |
